Loading…
Lobbying Spend
—
Filings
20
Firms Hired
1
Active Period
2022–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Increasing Medication Access for Seniors Act of 2024
2024 · fourth_quarter · Firm: VENABLE LLP
Implementation of Medicare Part D changes contained in Inflation Reduction Act: annual cap and smoothing Medicare Part B and Part D drug pricing Medicare Part D patient protections Medicare quality measures for and staffing of long-term care and skilled nursing facilities H.R. 8725 - Increasing Medication Access for Seniors Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8725
Increasing Medication Access for Seniors Act of 2024
2024 · third_quarter · Firm: VENABLE LLP
Implementation of Medicare Part D changes contained in Inflation Reduction Act: annual cap and smoothing Medicare Part B and Part D drug pricing Medicare Part D patient protections Medicare quality measures for and staffing of long-term care and skilled nursing facilities Medicare use of CED and QALY FY 2025 appropriations for FDA and HHS Medicare coverage of treatment of Alzheimer's H.R. 8725 - Increasing Medication Access for Seniors Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8725
To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.
2024 · second_quarter · Firm: VENABLE LLP
Implementation of Medicare Part D changes contained in Inflation Reduction Act: annual cap and smoothing / MP3 Medicare Part B and Part D drug pricing Part D patient protections Medicare quality measures for and staffing of long-term care and skilled nursing facilities Medicare use of CED and QALY FY 2025 appropriations for FDA and HHS HR 4096 - Medicaid coverage of antipsychotic medications Medicare coverage of treatment of Alzheimer's
Client expense: — · Firm income: $60,000
Matched citations: HR 4096
To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.
2024 · first_quarter · Firm: VENABLE LLP
Capping Medicare Part D Out of Pocket Costs Smoothing Medicare Part D Out of Pocket Costs Medicare Part B and Part D drug pricing Part D patient protections Medicare quality measures for and staffing of long-term care and skilled nursing facilities Implementation of Inflation Reduction Act Medicare use of CED and QALY FY 2024 and FY 2025 appropriations HR 4096 Medicare coverage of treatment of Alzheimer's
Client expense: — · Firm income: $60,000
Matched citations: HR 4096
To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.
2023 · fourth_quarter · Firm: VENABLE LLP
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for and staffing of long-term care and skilled nursing facilities; Implementation of Inflation Reduction Act; Medicare use of CED and QALY; Flat copay for Part D Medicare drugs; FY 2024 appropriations; HR 4096; Medicare coverage of treatment of Alzheimer's
Client expense: — · Firm income: $60,000
Matched citations: HR 4096
To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.
2023 · third_quarter · Firm: VENABLE LLP
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for long-term care and skilled nursing facilities; Implementation of Inflation Reduction Act; Medicare use of CED and QALY; Flat copay for Part D Medicare drugs; FY 2024 appropriations; HR 4096; Medicare coverage of treatment of Alzheimer's
Client expense: — · Firm income: $60,000
Matched citations: HR 4096
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act and its implementation.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5376
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act and its implementation.
Client expense: — · Firm income: $50,000
Matched citations: S. 2327
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5376
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act.
Client expense: — · Firm income: $50,000
Matched citations: S. 2327
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities.
Client expense: — · Firm income: $60,000
Matched citations: S. 2327
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities.
Client expense: — · Firm income: $50,000
Matched citations: S. 2327
Source: Senate LDA